DICLOXACILLIN AND FLUCLOXACILLIN INDUCE CYP3A4 AND CYP2C9 IN HUMAN HEPATOCYTES.

被引：0
|
作者：
Stage, T. B. [1 ]
Wong, S. [2 ]
Kroetz, D. L. [1 ]
Khojasteh, C. [2 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Genentech Inc, DMPK, San Francisco, CA 94080 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-107
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [1] Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro
    Stage, Tore Bjerregaard
    Graff, Magnus
    Wong, Susan
    Rasmussen, Louise Ladebo
    Nielsen, Flemming
    Pottegard, Anton
    Brosen, Kim
    Kroetz, Deanna L.
    Khojasteh, Cyrus
    Damkier, Per
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 510 - 519
  • [2] Troglitazone induces CYP3A4 in cultured human hepatocytes.
    LeCluyse, EL
    Sahi, J
    Sinz, M
    Woolf, T
    Hawke, R
    Hamilton, G
    Lesko, LJ
    Huang, SM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 157 - 157
  • [3] Evidence for CYP2C9:CYP3A4 enzyme activity interactions in human hepatocytes through modulation of enzyme levels
    Ramsden, Diane B.
    Chan, Tom S.
    Tracy, Timothy S.
    DRUG METABOLISM REVIEWS, 2011, 43 : 127 - 127
  • [4] Characterization of type II ligands in CYP2C9 and CYP3A4
    Ahlstrom, Marie M.
    Zamora, Ismael
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1755 - 1763
  • [5] The involvement of CYP3A4 and CYP2C9 in the metabolism of 17α-ethinylestradiol
    Wang, B
    Sanchez, RI
    Franklin, RB
    Evans, DC
    Huskey, SEW
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (11) : 1209 - 1212
  • [6] Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes
    Drocourt, L
    Ourlin, JC
    Pascussi, JM
    Maurel, P
    Vilarem, MJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) : 25125 - 25132
  • [7] Inhibitory Effects of Deoxypodophyllotoxin from Anthriscus sylvestris on Human CYP2C9 and CYP3A4
    Lee, Sang Kyu
    Kim, Yoon
    Jin, Changbae
    Lee, Seung Ho
    Kang, Mi Jeong
    Jeong, Tae Cheon
    Jeong, Seo Young
    Kim, Dong-Hyun
    Yoo, Hye Hyun
    PLANTA MEDICA, 2010, 76 (07) : 701 - 704
  • [8] Involvement of hepatic CYP2C9 and CYP3A4 in the metabolic activation of diclofenac.
    Tang, W
    Stearns, RA
    Wang, RW
    FASEB JOURNAL, 1998, 12 (04): : A145 - A145
  • [9] Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism
    Tang, Peng-fei
    Zheng, Xiang
    Hu, Xiao-xia
    Yang, Cheng-cheng
    Chen, Zhe
    Qian, Jian-chang
    Cai, Jian-ping
    Hu, Guo-xin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5129 - 5141
  • [10] Comparison of metasite and stardrop prediction of CYP3A4, CYP2C9 and CYP2D6
    Gopaul, V. Sashi
    Shin, Young
    Le, Hoa
    Baumgardner, Matthew
    Hop, Cornelis
    Khojasteh, Cyrus
    DRUG METABOLISM REVIEWS, 2009, 41 : 119 - 119
12345